BSE · GODAVARI
Godavari Drugs Ltd.
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,797
of 5,084 stocks
▲ 551W
Peak #2,768 · 27 Sep 2026
A microcap name in Healthcare, Godavari Drugs Ltd. is seeing revenue slip, trades at a moderate earnings multiple, and posts a modest return on equity.
Market Cap
122.04 Cr
P/E Ratio
22.19
P/B Ratio
1.61
ROE
5.39%
ROCE
7.54%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 27.96 Cr | 33.16 Cr | 22.18 Cr | 26.65 Cr |
| Net Profit | 1.11 Cr | 1.29 Cr | 75.76 L | 1.00 Cr |
| EPS | 1.10 | 1.71 | 1.01 | 1.33 |
| Operating Profit | 2.07 Cr | 2.47 Cr | 1.88 Cr | 2.03 Cr |
Shareholding pattern
Promoter
40.23%
Public
59.77%
PUBLIC BREAKDOWN
DII
2.74%
MF (within DII)
1.26%
Individuals
46.65%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.